Header Logo

Connection

Co-Authors

Back to Details
This is a "connection" page, showing publications co-authored by HUI-LIN PAN and SHAO-RUI CHEN.
HUI-LIN PAN
Connection Strength
24.269
SHAO-RUI CHEN
  1. Brief Opioid Exposure Paradoxically Augments Primary Afferent Input to Spinal Excitatory Neurons via a2d-1-Dependent Presynaptic NMDA Receptors. J Neurosci. 2022 12 14; 42(50):9315-9329.
    View in: PubMed
    Score: 0.864
  2. Streptozotocin-Induced Diabetic Neuropathic Pain Is Associated with Potentiated Calcium-Permeable AMPA Receptor Activity in the Spinal Cord. J Pharmacol Exp Ther. 2019 11; 371(2):242-249.
    View in: PubMed
    Score: 0.692
  3. Endogenous nitric oxide inhibits spinal NMDA receptor activity and pain hypersensitivity induced by nerve injury. Neuropharmacology. 2017 Oct; 125:156-165.
    View in: PubMed
    Score: 0.598
  4. Increased spinal cord Na?-K?-2Cl? cotransporter-1 (NKCC1) activity contributes to impairment of synaptic inhibition in paclitaxel-induced neuropathic pain. J Biol Chem. 2014 Nov 07; 289(45):31111-20.
    View in: PubMed
    Score: 0.491
  5. Casein kinase II regulates N-methyl-D-aspartate receptor activity in spinal cords and pain hypersensitivity induced by nerve injury. J Pharmacol Exp Ther. 2014 Aug; 350(2):301-12.
    View in: PubMed
    Score: 0.481
  6. Calcineurin inhibitor induces pain hypersensitivity by potentiating pre- and postsynaptic NMDA receptor activity in spinal cords. J Physiol. 2014 Jan 01; 592(1):215-27.
    View in: PubMed
    Score: 0.459
  7. Nerve injury increases GluA2-lacking AMPA receptor prevalence in spinal cords: functional significance and signaling mechanisms. J Pharmacol Exp Ther. 2013 Dec; 347(3):765-72.
    View in: PubMed
    Score: 0.458
  8. Increased presynaptic and postsynaptic a2-adrenoceptor activity in the spinal dorsal horn in painful diabetic neuropathy. J Pharmacol Exp Ther. 2011 Apr; 337(1):285-92.
    View in: PubMed
    Score: 0.381
  9. Antinociceptive effects of chronic administration of uncompetitive NMDA receptor antagonists in a rat model of diabetic neuropathic pain. Neuropharmacology. 2009 Aug; 57(2):121-6.
    View in: PubMed
    Score: 0.338
  10. Plasticity and emerging role of BKCa channels in nociceptive control in neuropathic pain. J Neurochem. 2009 Jul; 110(1):352-62.
    View in: PubMed
    Score: 0.338
  11. Removing TRPV1-expressing primary afferent neurons potentiates the spinal analgesic effect of delta-opioid agonists on mechano-nociception. Neuropharmacology. 2008 Aug; 55(2):215-22.
    View in: PubMed
    Score: 0.317
  12. Potentiation of spinal alpha(2)-adrenoceptor analgesia in rats deficient in TRPV1-expressing afferent neurons. Neuropharmacology. 2007 Jun; 52(8):1624-30.
    View in: PubMed
    Score: 0.292
  13. Resistance to morphine analgesic tolerance in rats with deleted transient receptor potential vanilloid type 1-expressing sensory neurons. Neuroscience. 2007 Mar 16; 145(2):676-85.
    View in: PubMed
    Score: 0.289
  14. Blocking mu opioid receptors in the spinal cord prevents the analgesic action by subsequent systemic opioids. Brain Res. 2006 Apr 07; 1081(1):119-25.
    View in: PubMed
    Score: 0.271
  15. Loss of TRPV1-expressing sensory neurons reduces spinal mu opioid receptors but paradoxically potentiates opioid analgesia. J Neurophysiol. 2006 May; 95(5):3086-96.
    View in: PubMed
    Score: 0.270
  16. Effect of systemic and intrathecal gabapentin on allodynia in a new rat model of postherpetic neuralgia. Brain Res. 2005 Apr 25; 1042(1):108-13.
    View in: PubMed
    Score: 0.256
  17. a2d-2 regulates synaptic GluK1 kainate receptors in Purkinje cells and motor coordination. Brain. 2024 Oct 23.
    View in: PubMed
    Score: 0.247
  18. Nerve injury augments Cacna2d1 transcription via CK2-mediated phosphorylation of the histone deacetylase HDAC2 in dorsal root ganglia. J Biol Chem. 2024 Nov; 300(11):107848.
    View in: PubMed
    Score: 0.246
  19. Distinct roles of group III metabotropic glutamate receptors in control of nociception and dorsal horn neurons in normal and nerve-injured Rats. J Pharmacol Exp Ther. 2005 Jan; 312(1):120-6.
    View in: PubMed
    Score: 0.245
  20. Sensing tissue ischemia: another new function for capsaicin receptors? Circulation. 2004 Sep 28; 110(13):1826-31.
    View in: PubMed
    Score: 0.245
  21. Calcineurin regulates synaptic Ca2+-permeable AMPA receptors in hypothalamic presympathetic neurons via a2d-1-mediated GluA1/GluA2 assembly. J Physiol. 2024 May; 602(10):2179-2197.
    View in: PubMed
    Score: 0.238
  22. Activation of muscarinic receptors inhibits spinal dorsal horn projection neurons: role of GABAB receptors. Neuroscience. 2004; 125(1):141-8.
    View in: PubMed
    Score: 0.234
  23. DNA demethylation in the hypothalamus promotes transcription of Agtr1a and Slc12a2 and hypertension development. J Biol Chem. 2024 Feb; 300(2):105597.
    View in: PubMed
    Score: 0.233
  24. Antinociceptive effect of morphine, but not mu opioid receptor number, is attenuated in the spinal cord of diabetic rats. Anesthesiology. 2003 Dec; 99(6):1409-14.
    View in: PubMed
    Score: 0.232
  25. Up-regulation of spinal muscarinic receptors and increased antinociceptive effect of intrathecal muscarine in diabetic rats. J Pharmacol Exp Ther. 2003 Nov; 307(2):676-81.
    View in: PubMed
    Score: 0.229
  26. Brain a2d-1-Bound NMDA Receptors Drive Calcineurin Inhibitor-Induced Hypertension. Circ Res. 2023 09 15; 133(7):611-627.
    View in: PubMed
    Score: 0.228
  27. mGluR5 from Primary Sensory Neurons Promotes Opioid-Induced Hyperalgesia and Tolerance by Interacting with and Potentiating Synaptic NMDA Receptors. J Neurosci. 2023 08 02; 43(31):5593-5607.
    View in: PubMed
    Score: 0.226
  28. NMDA Receptors at Primary Afferent-Excitatory Neuron Synapses Differentially Sustain Chemotherapy- and Nerve Trauma-Induced Chronic Pain. J Neurosci. 2023 05 24; 43(21):3933-3948.
    View in: PubMed
    Score: 0.223
  29. Resiniferatoxin induces paradoxical changes in thermal and mechanical sensitivities in rats: mechanism of action. J Neurosci. 2003 Apr 01; 23(7):2911-9.
    View in: PubMed
    Score: 0.222
  30. Duloxetine and Amitriptyline Reduce Neuropathic Pain by Inhibiting Primary Sensory Input to Spinal Dorsal Horn Neurons via a1- and a2-Adrenergic Receptors. ACS Chem Neurosci. 2023 04 05; 14(7):1261-1277.
    View in: PubMed
    Score: 0.221
  31. Spinal GABAB receptors mediate antinociceptive actions of cholinergic agents in normal and diabetic rats. Brain Res. 2003 Mar 07; 965(1-2):67-74.
    View in: PubMed
    Score: 0.221
  32. Spinal nitric oxide contributes to the analgesic effect of intrathecal [d-pen2,d-pen5]-enkephalin in normal and diabetic rats. Anesthesiology. 2003 Jan; 98(1):217-22.
    View in: PubMed
    Score: 0.218
  33. Functional mu opioid receptors are reduced in the spinal cord dorsal horn of diabetic rats. Anesthesiology. 2002 Dec; 97(6):1602-8.
    View in: PubMed
    Score: 0.217
  34. a2d-1 protein drives opioid-induced conditioned reward and synaptic NMDA receptor hyperactivity in the nucleus accumbens. J Neurochem. 2023 01; 164(2):143-157.
    View in: PubMed
    Score: 0.215
  35. HDAC2 in Primary Sensory Neurons Constitutively Restrains Chronic Pain by Repressing a2d-1 Expression and Associated NMDA Receptor Activity. J Neurosci. 2022 11 30; 42(48):8918-8935.
    View in: PubMed
    Score: 0.215
  36. d-Opioid receptors in primary sensory neurons tonically restrain nociceptive input in chronic pain but do not enhance morphine analgesic tolerance. Neuropharmacology. 2022 10 01; 217:109202.
    View in: PubMed
    Score: 0.212
  37. Calcineurin Controls Hypothalamic NMDA Receptor Activity and Sympathetic Outflow. Circ Res. 2022 08 05; 131(4):345-360.
    View in: PubMed
    Score: 0.211
  38. Hypersensitivity of spinothalamic tract neurons associated with diabetic neuropathic pain in rats. J Neurophysiol. 2002 Jun; 87(6):2726-33.
    View in: PubMed
    Score: 0.209
  39. Cannabinoid CB2 receptors are upregulated via bivalent histone modifications and control primary afferent input to the spinal cord in neuropathic pain. J Biol Chem. 2022 06; 298(6):101999.
    View in: PubMed
    Score: 0.208
  40. a2d-1 protein promotes synaptic expression of Ca2+ permeable-AMPA receptors by inhibiting GluA1/GluA2 heteromeric assembly in the hypothalamus in hypertension. J Neurochem. 2022 04; 161(1):40-52.
    View in: PubMed
    Score: 0.205
  41. Effect of 2-(phosphono-methyl)-pentanedioic acid on allodynia and afferent ectopic discharges in a rat model of neuropathic pain. J Pharmacol Exp Ther. 2002 Feb; 300(2):662-7.
    View in: PubMed
    Score: 0.205
  42. Myocardial ischemia recruits mechanically insensitive cardiac sympathetic afferents in cats. J Neurophysiol. 2002 Feb; 87(2):660-8.
    View in: PubMed
    Score: 0.205
  43. Corrigendum to "LRRC8A-dependent volume-regulated anion channels contribute to ischemia-induced brain injury and glutamatergic input to hippocampal neurons" [Experimental Neurology, 332(2020)113391]. Exp Neurol. 2022 Mar; 349:113956.
    View in: PubMed
    Score: 0.203
  44. Theta-Burst Stimulation of Primary Afferents Drives Long-Term Potentiation in the Spinal Cord and Persistent Pain via a2d-1-Bound NMDA Receptors. J Neurosci. 2022 01 19; 42(3):513-527.
    View in: PubMed
    Score: 0.202
  45. Stereospecific effect of pregabalin on ectopic afferent discharges and neuropathic pain induced by sciatic nerve ligation in rats. Anesthesiology. 2001 Dec; 95(6):1473-9.
    View in: PubMed
    Score: 0.202
  46. Calcineurin Regulates Synaptic Plasticity and Nociceptive Transmission at the Spinal Cord Level. Neuroscientist. 2022 12; 28(6):628-638.
    View in: PubMed
    Score: 0.202
  47. Antiallodynic effect of intrathecal neostigmine is mediated by spinal nitric oxide in a rat model of diabetic neuropathic pain. Anesthesiology. 2001 Oct; 95(4):1007-12.
    View in: PubMed
    Score: 0.200
  48. Spinal endogenous acetylcholine contributes to the analgesic effect of systemic morphine in rats. Anesthesiology. 2001 Aug; 95(2):525-30.
    View in: PubMed
    Score: 0.198
  49. a2d-1 switches the phenotype of synaptic AMPA receptors by physically disrupting heteromeric subunit assembly. Cell Rep. 2021 07 20; 36(3):109396.
    View in: PubMed
    Score: 0.197
  50. a2d-1-Dependent NMDA Receptor Activity in the Hypothalamus Is an Effector of Genetic-Environment Interactions That Drive Persistent Hypertension. J Neurosci. 2021 07 28; 41(30):6551-6563.
    View in: PubMed
    Score: 0.196
  51. Protein Kinase C-Mediated Phosphorylation and a2d-1 Interdependently Regulate NMDA Receptor Trafficking and Activity. J Neurosci. 2021 07 28; 41(30):6415-6429.
    View in: PubMed
    Score: 0.196
  52. a2d-1 Upregulation in Primary Sensory Neurons Promotes NMDA Receptor-Mediated Glutamatergic Input in Resiniferatoxin-Induced Neuropathy. J Neurosci. 2021 07 07; 41(27):5963-5978.
    View in: PubMed
    Score: 0.196
  53. Differential responses of regional sympathetic activity and blood flow to visceral afferent stimulation. Am J Physiol Regul Integr Comp Physiol. 2001 Jun; 280(6):R1781-9.
    View in: PubMed
    Score: 0.195
  54. LRRC8A-dependent volume-regulated anion channels contribute to ischemia-induced brain injury and glutamatergic input to hippocampal neurons. Exp Neurol. 2020 10; 332:113391.
    View in: PubMed
    Score: 0.183
  55. Group III metabotropic glutamate receptors regulate hypothalamic presympathetic neurons through opposing presynaptic and postsynaptic actions in hypertension. Neuropharmacology. 2020 09 01; 174:108159.
    View in: PubMed
    Score: 0.182
  56. Histone methyltransferase G9a diminishes expression of cannabinoid CB1 receptors in primary sensory neurons in neuropathic pain. J Biol Chem. 2020 03 13; 295(11):3553-3562.
    View in: PubMed
    Score: 0.178
  57. Synergistic effect between intrathecal non-NMDA antagonist and gabapentin on allodynia induced by spinal nerve ligation in rats. Anesthesiology. 2000 Feb; 92(2):500-6.
    View in: PubMed
    Score: 0.178
  58. Intrathecal S-nitroso-N-acetylpenicillamine and L-cysteine attenuate nerve injury-induced allodynia through noradrenergic activation in rats. Neuroscience. 2000; 101(3):759-65.
    View in: PubMed
    Score: 0.177
  59. ?-Opioid receptors in primary sensory neurons are involved in supraspinal opioid analgesia. Brain Res. 2020 02 15; 1729:146623.
    View in: PubMed
    Score: 0.177
  60. Role of protons in activation of cardiac sympathetic C-fibre afferents during ischaemia in cats. J Physiol. 1999 Aug 01; 518 ( Pt 3):857-66.
    View in: PubMed
    Score: 0.172
  61. Endogenous AT1 receptor-protein kinase C activity in the hypothalamus augments glutamatergic input and sympathetic outflow in hypertension. J Physiol. 2019 08; 597(16):4325-4340.
    View in: PubMed
    Score: 0.171
  62. a2d-1-Bound N-Methyl-D-aspartate Receptors Mediate Morphine-induced Hyperalgesia and Analgesic Tolerance by Potentiating Glutamatergic Input in Rodents. Anesthesiology. 2019 05; 130(5):804-819.
    View in: PubMed
    Score: 0.169
  63. Endogenous transient receptor potential ankyrin 1 and vanilloid 1 activity potentiates glutamatergic input to spinal lamina I neurons in inflammatory pain. J Neurochem. 2019 05; 149(3):381-398.
    View in: PubMed
    Score: 0.168
  64. Gabapentin suppresses ectopic nerve discharges and reverses allodynia in neuropathic rats. J Pharmacol Exp Ther. 1999 Mar; 288(3):1026-30.
    View in: PubMed
    Score: 0.167
  65. Presynaptic NMDA receptors control nociceptive transmission at the spinal cord level in neuropathic pain. Cell Mol Life Sci. 2019 May; 76(10):1889-1899.
    View in: PubMed
    Score: 0.167
  66. ?-Opioid receptors in primary sensory neurons are essential for opioid analgesic effect on acute and inflammatory pain and opioid-induced hyperalgesia. J Physiol. 2019 03; 597(6):1661-1675.
    View in: PubMed
    Score: 0.166
  67. Increased a2d-1-NMDA receptor coupling potentiates glutamatergic input to spinal dorsal horn neurons in chemotherapy-induced neuropathic pain. J Neurochem. 2019 01; 148(2):252-274.
    View in: PubMed
    Score: 0.165
  68. Mitogen-activated protein kinase signaling mediates opioid-induced presynaptic NMDA receptor activation and analgesic tolerance. J Neurochem. 2019 01; 148(2):275-290.
    View in: PubMed
    Score: 0.165
  69. Regulating nociceptive transmission by VGluT2-expressing spinal dorsal horn neurons. J Neurochem. 2018 11; 147(4):526-540.
    View in: PubMed
    Score: 0.163
  70. RE1-silencing transcription factor controls the acute-to-chronic neuropathic pain transition and Chrm2 receptor gene expression in primary sensory neurons. J Biol Chem. 2018 12 07; 293(49):19078-19091.
    View in: PubMed
    Score: 0.163
  71. Focal Cerebral Ischemia and Reperfusion Induce Brain Injury Through a2d-1-Bound NMDA Receptors. Stroke. 2018 10; 49(10):2464-2472.
    View in: PubMed
    Score: 0.162
  72. a2d-1 couples to NMDA receptors in the hypothalamus to sustain sympathetic vasomotor activity in hypertension. J Physiol. 2018 09; 596(17):4269-4283.
    View in: PubMed
    Score: 0.160
  73. a2d-1 Is Essential for Sympathetic Output and NMDA Receptor Activity Potentiated by Angiotensin II in the Hypothalamus. J Neurosci. 2018 07 11; 38(28):6388-6398.
    View in: PubMed
    Score: 0.159
  74. The a2d-1-NMDA Receptor Complex Is Critically Involved in Neuropathic Pain Development and Gabapentin Therapeutic Actions. Cell Rep. 2018 02 27; 22(9):2307-2321.
    View in: PubMed
    Score: 0.156
  75. Bortezomib induces neuropathic pain through protein kinase C-mediated activation of presynaptic NMDA receptors in the spinal cord. Neuropharmacology. 2017 Sep 01; 123:477-487.
    View in: PubMed
    Score: 0.149
  76. Ghrelin receptors mediate ghrelin-induced excitation of agouti-related protein/neuropeptide Y but not pro-opiomelanocortin neurons. J Neurochem. 2017 08; 142(4):512-520.
    View in: PubMed
    Score: 0.149
  77. Chloride Homeostasis Critically Regulates Synaptic NMDA Receptor Activity in Neuropathic Pain. Cell Rep. 2016 05 17; 15(7):1376-1383.
    View in: PubMed
    Score: 0.137
  78. Nerve Injury Diminishes Opioid Analgesia through Lysine Methyltransferase-mediated Transcriptional Repression of ?-Opioid Receptors in Primary Sensory Neurons. J Biol Chem. 2016 Apr 15; 291(16):8475-85.
    View in: PubMed
    Score: 0.136
  79. Muscarinic receptor subtypes differentially control synaptic input and excitability of cerebellum-projecting medial vestibular nucleus neurons. J Neurochem. 2016 Apr; 137(2):226-39.
    View in: PubMed
    Score: 0.135
  80. G9a is essential for epigenetic silencing of K(+) channel genes in acute-to-chronic pain transition. Nat Neurosci. 2015 Dec; 18(12):1746-55.
    View in: PubMed
    Score: 0.133
  81. Pannexin-1 Up-regulation in the Dorsal Root Ganglion Contributes to Neuropathic Pain Development. J Biol Chem. 2015 Jun 05; 290(23):14647-55.
    View in: PubMed
    Score: 0.128
  82. Potentiation of high voltage-activated calcium channels by 4-aminopyridine depends on subunit composition. Mol Pharmacol. 2014 Dec; 86(6):760-72.
    View in: PubMed
    Score: 0.123
  83. Protein kinase CK2 contributes to diminished small conductance Ca2+-activated K+ channel activity of hypothalamic pre-sympathetic neurons in hypertension. J Neurochem. 2014 Sep; 130(5):657-67.
    View in: PubMed
    Score: 0.120
  84. Differential regulation of primary afferent input to spinal cord by muscarinic receptor subtypes delineated using knockout mice. J Biol Chem. 2014 May 16; 289(20):14321-30.
    View in: PubMed
    Score: 0.119
  85. Casein kinase II inhibition reverses pain hypersensitivity and potentiated spinal N-methyl-D-aspartate receptor activity caused by calcineurin inhibitor. J Pharmacol Exp Ther. 2014 May; 349(2):239-47.
    View in: PubMed
    Score: 0.118
  86. Regulation of nociceptive transduction and transmission by nitric oxide. Vitam Horm. 2014; 96:1-18.
    View in: PubMed
    Score: 0.117
  87. Distinct intrinsic and synaptic properties of pre-sympathetic and pre-parasympathetic output neurons in Barrington's nucleus. J Neurochem. 2013 Aug; 126(3):338-48.
    View in: PubMed
    Score: 0.112
  88. Upregulation of nuclear factor of activated T-cells by nerve injury contributes to development of neuropathic pain. J Pharmacol Exp Ther. 2013 Apr; 345(1):161-8.
    View in: PubMed
    Score: 0.110
  89. N-methyl-D-aspartate receptor- and calpain-mediated proteolytic cleavage of K+-Cl- cotransporter-2 impairs spinal chloride homeostasis in neuropathic pain. J Biol Chem. 2012 Sep 28; 287(40):33853-64.
    View in: PubMed
    Score: 0.106
  90. Chronic opioid potentiates presynaptic but impairs postsynaptic N-methyl-D-aspartic acid receptor activity in spinal cords: implications for opioid hyperalgesia and tolerance. J Biol Chem. 2012 Jul 20; 287(30):25073-85.
    View in: PubMed
    Score: 0.105
  91. Nerve injury increases brain-derived neurotrophic factor levels to suppress BK channel activity in primary sensory neurons. J Neurochem. 2012 Jun; 121(6):944-53.
    View in: PubMed
    Score: 0.104
  92. Up-regulation of Cav?3 subunit in primary sensory neurons increases voltage-activated Ca2+ channel activity and nociceptive input in neuropathic pain. J Biol Chem. 2012 Feb 17; 287(8):6002-13.
    View in: PubMed
    Score: 0.101
  93. Diabetic neuropathy enhances voltage-activated Ca2+ channel activity and its control by M4 muscarinic receptors in primary sensory neurons. J Neurochem. 2011 Nov; 119(3):594-603.
    View in: PubMed
    Score: 0.100
  94. Nitric oxide inhibits nociceptive transmission by differentially regulating glutamate and glycine release to spinal dorsal horn neurons. J Biol Chem. 2011 Sep 23; 286(38):33190-202.
    View in: PubMed
    Score: 0.099
  95. Targeting N-methyl-D-aspartate receptors for treatment of neuropathic pain. Expert Rev Clin Pharmacol. 2011 May; 4(3):379-88.
    View in: PubMed
    Score: 0.097
  96. Dynamic control of glutamatergic synaptic input in the spinal cord by muscarinic receptor subtypes defined using knockout mice. J Biol Chem. 2010 Dec 24; 285(52):40427-37.
    View in: PubMed
    Score: 0.093
  97. Functional plasticity of group II metabotropic glutamate receptors in regulating spinal excitatory and inhibitory synaptic input in neuropathic pain. J Pharmacol Exp Ther. 2011 Jan; 336(1):254-64.
    View in: PubMed
    Score: 0.093
  98. Reduction in voltage-gated K+ channel activity in primary sensory neurons in painful diabetic neuropathy: role of brain-derived neurotrophic factor. J Neurochem. 2010 Sep 01; 114(5):1460-75.
    View in: PubMed
    Score: 0.092
  99. Opioid-induced long-term potentiation in the spinal cord is a presynaptic event. J Neurosci. 2010 Mar 24; 30(12):4460-6.
    View in: PubMed
    Score: 0.090
  100. Adenosine inhibits paraventricular pre-sympathetic neurons through ATP-dependent potassium channels. J Neurochem. 2010 Apr; 113(2):530-42.
    View in: PubMed
    Score: 0.089
  101. Aminopyridines potentiate synaptic and neuromuscular transmission by targeting the voltage-activated calcium channel beta subunit. J Biol Chem. 2009 Dec 25; 284(52):36453-36461.
    View in: PubMed
    Score: 0.087
  102. Regulation of increased glutamatergic input to spinal dorsal horn neurons by mGluR5 in diabetic neuropathic pain. J Neurochem. 2010 Jan; 112(1):162-72.
    View in: PubMed
    Score: 0.087
  103. Role of M2, M3, and M4 muscarinic receptor subtypes in the spinal cholinergic control of nociception revealed using siRNA in rats. J Neurochem. 2009 Nov; 111(4):1000-10.
    View in: PubMed
    Score: 0.087
  104. Sensing of blood pressure increase by transient receptor potential vanilloid 1 receptors on baroreceptors. J Pharmacol Exp Ther. 2009 Dec; 331(3):851-9.
    View in: PubMed
    Score: 0.087
  105. Signaling mechanisms mediating muscarinic enhancement of GABAergic synaptic transmission in the spinal cord. Neuroscience. 2009 Feb 18; 158(4):1577-88.
    View in: PubMed
    Score: 0.082
  106. Stimulation of alpha(1)-adrenoceptors reduces glutamatergic synaptic input from primary afferents through GABA(A) receptors and T-type Ca(2+) channels. Neuroscience. 2009 Feb 18; 158(4):1616-24.
    View in: PubMed
    Score: 0.082
  107. The glutamatergic nature of TRPV1-expressing neurons in the spinal dorsal horn. J Neurochem. 2009 Jan; 108(1):305-18.
    View in: PubMed
    Score: 0.082
  108. Effects of activation of group III metabotropic glutamate receptors on spinal synaptic transmission in a rat model of neuropathic pain. Neuroscience. 2009 Jan 23; 158(2):875-84.
    View in: PubMed
    Score: 0.082
  109. Sustained inhibition of neurotransmitter release from nontransient receptor potential vanilloid type 1-expressing primary afferents by mu-opioid receptor activation-enkephalin in the spinal cord. J Pharmacol Exp Ther. 2008 Nov; 327(2):375-82.
    View in: PubMed
    Score: 0.080
  110. Distinct inhibition of voltage-activated Ca2+ channels by delta-opioid agonists in dorsal root ganglion neurons devoid of functional T-type Ca2+ currents. Neuroscience. 2008 Jun 02; 153(4):1256-67.
    View in: PubMed
    Score: 0.078
  111. Increased C-fiber nociceptive input potentiates inhibitory glycinergic transmission in the spinal dorsal horn. J Pharmacol Exp Ther. 2008 Mar; 324(3):1000-10.
    View in: PubMed
    Score: 0.077
  112. Modulation of pain transmission by G-protein-coupled receptors. Pharmacol Ther. 2008 Jan; 117(1):141-61.
    View in: PubMed
    Score: 0.076
  113. Kv1.1/1.2 channels are downstream effectors of nitric oxide on synaptic GABA release to preautonomic neurons in the paraventricular nucleus. Neuroscience. 2007 Oct 26; 149(2):315-27.
    View in: PubMed
    Score: 0.075
  114. Altered synaptic input and GABAB receptor function in spinal superficial dorsal horn neurons in rats with diabetic neuropathy. J Physiol. 2007 Mar 15; 579(Pt 3):849-61.
    View in: PubMed
    Score: 0.072
  115. Increased nociceptive input rapidly modulates spinal GABAergic transmission through endogenously released glutamate. J Neurophysiol. 2007 Jan; 97(1):871-82.
    View in: PubMed
    Score: 0.071
  116. Regulation of glutamate release from primary afferents and interneurons in the spinal cord by muscarinic receptor subtypes. J Neurophysiol. 2007 Jan; 97(1):102-9.
    View in: PubMed
    Score: 0.071
  117. Signaling mechanisms of down-regulation of voltage-activated Ca2+ channels by transient receptor potential vanilloid type 1 stimulation with olvanil in primary sensory neurons. Neuroscience. 2006 Aug 11; 141(1):407-19.
    View in: PubMed
    Score: 0.069
  118. Dynamic regulation of glycinergic input to spinal dorsal horn neurones by muscarinic receptor subtypes in rats. J Physiol. 2006 Mar 01; 571(Pt 2):403-13.
    View in: PubMed
    Score: 0.067
  119. Mu opioid receptor activation inhibits GABAergic inputs to basolateral amygdala neurons through Kv1.1/1.2 channels. J Neurophysiol. 2006 Apr; 95(4):2032-41.
    View in: PubMed
    Score: 0.067
  120. Effect of morphine on deep dorsal horn projection neurons depends on spinal GABAergic and glycinergic tone: implications for reduced opioid effect in neuropathic pain. J Pharmacol Exp Ther. 2005 Nov; 315(2):696-703.
    View in: PubMed
    Score: 0.065
  121. Systemic morphine inhibits dorsal horn projection neurons through spinal cholinergic system independent of descending pathways. J Pharmacol Exp Ther. 2005 Aug; 314(2):611-7.
    View in: PubMed
    Score: 0.064
  122. Functional activity of the M2 and M4 receptor subtypes in the spinal cord studied with muscarinic acetylcholine receptor knockout mice. J Pharmacol Exp Ther. 2005 May; 313(2):765-70.
    View in: PubMed
    Score: 0.063
  123. A-type voltage-gated K+ currents influence firing properties of isolectin B4-positive but not isolectin B4-negative primary sensory neurons. J Neurophysiol. 2005 Jun; 93(6):3401-9.
    View in: PubMed
    Score: 0.063
  124. M2, M3, and M4 receptor subtypes contribute to muscarinic potentiation of GABAergic inputs to spinal dorsal horn neurons. J Pharmacol Exp Ther. 2005 May; 313(2):697-704.
    View in: PubMed
    Score: 0.063
  125. Effect of the {mu} opioid on excitatory and inhibitory synaptic inputs to periaqueductal gray-projecting neurons in the amygdala. J Pharmacol Exp Ther. 2005 Feb; 312(2):441-8.
    View in: PubMed
    Score: 0.061
  126. Regulation of synaptic inputs to paraventricular-spinal output neurons by alpha2 adrenergic receptors. J Neurophysiol. 2005 Jan; 93(1):393-402.
    View in: PubMed
    Score: 0.061
  127. Differential sensitivity of N- and P/Q-type Ca2+ channel currents to a mu opioid in isolectin B4-positive and -negative dorsal root ganglion neurons. J Pharmacol Exp Ther. 2004 Dec; 311(3):939-47.
    View in: PubMed
    Score: 0.061
  128. VR1 receptor activation induces glutamate release and postsynaptic firing in the paraventricular nucleus. J Neurophysiol. 2004 Sep; 92(3):1807-16.
    View in: PubMed
    Score: 0.060
  129. Activation of mu-opioid receptors excites a population of locus coeruleus-spinal neurons through presynaptic disinhibition. Brain Res. 2004 Jan 30; 997(1):67-78.
    View in: PubMed
    Score: 0.059
  130. Activation of mu-opioid receptors inhibits synaptic inputs to spinally projecting rostral ventromedial medulla neurons. J Pharmacol Exp Ther. 2004 May; 309(2):476-83.
    View in: PubMed
    Score: 0.059
  131. Signalling pathway of nitric oxide in synaptic GABA release in the rat paraventricular nucleus. J Physiol. 2004 Jan 01; 554(Pt 1):100-10.
    View in: PubMed
    Score: 0.058
  132. Cardiac vanilloid receptor 1-expressing afferent nerves and their role in the cardiogenic sympathetic reflex in rats. J Physiol. 2003 Sep 01; 551(Pt 2):515-23.
    View in: PubMed
    Score: 0.056
  133. Angiotensin II stimulates spinally projecting paraventricular neurons through presynaptic disinhibition. J Neurosci. 2003 Jun 15; 23(12):5041-9.
    View in: PubMed
    Score: 0.056
  134. Role of spinal nitric oxide in the inhibitory effect of [D-Pen2, D-Pen5]-enkephalin on ascending dorsal horn neurons in normal and diabetic rats. J Pharmacol Exp Ther. 2002 Dec; 303(3):1021-8.
    View in: PubMed
    Score: 0.054
  135. Nitric oxide inhibits spinally projecting paraventricular neurons through potentiation of presynaptic GABA release. J Neurophysiol. 2002 Nov; 88(5):2664-74.
    View in: PubMed
    Score: 0.054
  136. Activation of delta-opioid receptors excites spinally projecting locus coeruleus neurons through inhibition of GABAergic inputs. J Neurophysiol. 2002 Nov; 88(5):2675-83.
    View in: PubMed
    Score: 0.054
  137. Role of presynaptic muscarinic and GABA(B) receptors in spinal glutamate release and cholinergic analgesia in rats. J Physiol. 2002 Sep 15; 543(Pt 3):807-18.
    View in: PubMed
    Score: 0.053
  138. Role of primary afferent nerves in allodynia caused by diabetic neuropathy in rats. Neuroscience. 2002; 114(2):291-9.
    View in: PubMed
    Score: 0.051
  139. Cardiac interstitial bradykinin release during ischemia is enhanced by ischemic preconditioning. Am J Physiol Heart Circ Physiol. 2000 Jul; 279(1):H116-21.
    View in: PubMed
    Score: 0.046
  140. Role of spinal muscarinic and nicotinic receptors in clonidine-induced nitric oxide release in a rat model of neuropathic pain. Brain Res. 2000 Apr 10; 861(2):390-8.
    View in: PubMed
    Score: 0.045
  141. Spinal cyclooxygenase-2 is involved in development of allodynia after nerve injury in rats. Neuroscience. 2000; 97(4):743-8.
    View in: PubMed
    Score: 0.044
  142. Intrathecal clonidine alleviates allodynia in neuropathic rats: interaction with spinal muscarinic and nicotinic receptors. Anesthesiology. 1999 Feb; 90(2):509-14.
    View in: PubMed
    Score: 0.042
  143. Role of spinal NO in antiallodynic effect of intrathecal clonidine in neuropathic rats. Anesthesiology. 1998 Dec; 89(6):1518-23.
    View in: PubMed
    Score: 0.041
  144. Hyper-SUMOylation of the Kv7 potassium channel diminishes the M-current leading to seizures and sudden death. Neuron. 2014 Sep 03; 83(5):1159-71.
    View in: PubMed
    Score: 0.031
  145. Presynaptic glycine receptors as a potential therapeutic target for hyperekplexia disease. Nat Neurosci. 2014 Feb; 17(2):232-9.
    View in: PubMed
    Score: 0.029
  146. Mastering tricyclic ring systems for desirable functional cannabinoid activity. Eur J Med Chem. 2013 Nov; 69:881-907.
    View in: PubMed
    Score: 0.029
  147. Cannabinoids suppress inflammatory and neuropathic pain by targeting a3 glycine receptors. J Exp Med. 2012 Jun 04; 209(6):1121-34.
    View in: PubMed
    Score: 0.026
  148. Control of glycinergic input to spinal dorsal horn neurons by distinct muscarinic receptor subtypes revealed using knockout mice. J Pharmacol Exp Ther. 2007 Dec; 323(3):963-71.
    View in: PubMed
    Score: 0.019
  149. Opposing functions of spinal M2, M3, and M4 receptor subtypes in regulation of GABAergic inputs to dorsal horn neurons revealed by muscarinic receptor knockout mice. Mol Pharmacol. 2006 Mar; 69(3):1048-55.
    View in: PubMed
    Score: 0.017
  150. Effect of kappa opioid agonists on visceral nociception induced by uterine cervical distension in rats. Pain. 2002 Mar; 96(1-2):13-22.
    View in: PubMed
    Score: 0.013
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.